Follow Us:
Sunday, October 25, 2020

pharmaceutical sector


Low demand, raw material shortage: pharma sector yet to bounce back

July 24, 2020 11:34 am

According to Munish Thakur, general secretary of the Himachal Drug Manufacturers’ Association (HDMA), a majority of the plants are running at a production capacity of around 70 per cent.

Punjab’s big plan for plant land: a pharma park, if Centre grants nod

June 24, 2020 1:45 pm

The Finance Minister said that if a pharmaceutical park comes up in Bathinda, it will be a win-win situation for the area.

‘Bioabsorbable’ stent: NPPA defers price cap exemption decision, cites ‘discrepant’ documents

December 17, 2019 5:04 am

According to the regulator, the firm has submitted a patent document for a ‘bioabsorbable’ stent, but its licence from the Drug Controller General of India (DCGI) was for a ‘bioresorbable’ stent.

A band-aid

December 16, 2019 12:45 am

Raising prices of essential drugs will help ease shortage. Urgency of investing more in R&D remains.

GSK recalls acidity tablet Zinetac amid concerns over cancer-causing contaminants

September 26, 2019 3:13 pm

Zinetac medicine recalled: Ranitidine, a medicine that decreases stomach acid production, had a market size of Rs 688.6 crore in India and Zinetac was the second largest brand in this segment as of August 2019, according to AIOCD Awacs PharmaTrac.

China’s new drug law may open the doors for Indian generic medicines

August 29, 2019 4:15 am

India has been demanding that China open its pharmaceutical market to Indian drugs as part of the efforts to lower the $57 billion trade deficit in about $95.5 billion total trade last year.

Retail margins of 42 cancer drugs capped at 30 per cent

February 28, 2019 3:17 am

The National Pharmaceutical Pricing Authority (NPPA) in a notification stated that it was invoking extraordinary powers under drug pricing regulations “in public interest” to cap the trade margins of these medicines.

Paracetamol sales rising but firms’ revenue suffers due to price cuts

July 10, 2018 12:50 am

Over 200 paracetamol brands are sold in India. In 2017-18, 4.77 lakh tablets worth Rs 1,008 crore were sold in India, according to the data.

Pharma Sector: 80 per cent APIs via Chinese imports despite similar making costs

June 19, 2018 6:06 am

This is despite the cost of manufacturing APIs being similar in India as well as China, according to a study released by commerce minister Suresh Prabhu on Monday.

US: Don’t insist on localisation for ‘Make in India’

November 26, 2014 1:12 am

Issues related to visas and enhanced market access for agri products were discussed by Nirmala Sitharaman and Michael Froman.